Verano Holdings

Legalization And Plant-Based Wellness Will Unlock Expansive Cannabis Markets

AnalystHighTarget

Not Invested

Consensus Narrative from 6 Analysts

Published

10 Aug 25

Updated

10 Aug 25

AnalystHighTarget's Fair Value

CA$6.00

65.8% undervalued

10 Aug

CA$2.05

-62.0%

78.3%

Author's Valuation

CA$6.0

65.8% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

CA$6.0

65.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

2.93%

Pharma revenue growth rate

1.09%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.39%

Calculation

US$25.68m

Earnings '28

85.54x

PE Ratio '28

US$2.20b

Market Cap '28

US$2.20b

Market Cap '28

412.08m

No. shares '28

US$5.33

Share Price '28

US$5.33 Share Price '28

Discounted to 2025 @ 6.93% p.a.

US$4.36

Fair Value '25

US$4.36 Fair Value '25

Converted to CAD @ 1.3757 USD/CAD Exchange Rate

CA$6.00

Fair Value '25